Insider · CIK 0002120170
Wenbei Wang
Files at BZ (Kanzhun Ltd). First filing Mar 24, 2026, latest Apr 1, 2026.
In brief
Wenbei Wang files SEC Form 4 as CFO at BZ (Kanzhun Ltd). Since Mar 24, 2026, Wenbei Wang has reported 0 open-market buys worth $0 and 2 open-market sells worth $5,581, the latest filed on Apr 1, 2026.
A track record needs three past buys with six months of prices behind them; Wenbei Wang has 0, so none is measured yet.
The newest scored trade: sold $5,447 of BZ on Mar 30, 2026, filed Apr 1, 2026, scored 22 (weak). In the last 12 months: 0 buys worth $0 and 2 sells worth $5,581.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BZ: Kanzhun Ltd
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | Kanzhun Ltd | $5,447 814 shares | -1% | +2% from low-46% from high | |
| 22Weak | Kanzhun Ltd | $134 20 shares | -0% | +2% from low-45% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jun 15, 2026 | BZ Kanzhun Limited | 6,500 0.00% of outstanding | $89k | Jun 15, 2026 | $134 |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | BZ Kanzhun Ltd | MOption exercise Class A ordinary shares | +65,000 | - | - | 213,588 | 25 d ago |
| Sep 17, 2026 | BZ Kanzhun Ltd | MOption exercise Restricted Share Unitderivative | -40,000 | $0.00 | $0 | 40,000 | 25 d ago |
| Sep 17, 2026 | BZ Kanzhun Ltd | MOption exercise Restricted Share Unitderivative | -25,000 | $0.00 | $0 | 75,000 | 25 d ago |
| Jun 16, 2026 | BZ Kanzhun Ltd | MOption exercise Class A ordinary shares | +25,000 | - | - | 148,588 | Jun 17, 2026 |
| Jun 16, 2026 | BZ Kanzhun Ltd | MOption exercise Restricted Share Unitderivative | -25,000 | $0.00 | $0 | 0 | Jun 17, 2026 |
| Mar 30, 2026 | BZ Kanzhun Ltd | MOption exercise Class A ordinary shares | +54,242 | - | - | 124,402 | Apr 1, 2026 |
| Mar 30, 2026 | BZ Kanzhun Ltd | SOpen-market sale Class A ordinary shares | -814 | $6.69 | $5,447 | 123,588 | Apr 1, 2026 |
| Mar 30, 2026 | BZ Kanzhun Ltd | MOption exercise Restricted Share Unitderivative | -54,242 | $0.00 | $0 | 54,244 | Apr 1, 2026 |
| Mar 20, 2026 | BZ Kanzhun Ltd | MOption exercise Class A ordinary shares | +4,308 | - | - | 70,180 | Mar 24, 2026 |
| Mar 20, 2026 | BZ Kanzhun Ltd | SOpen-market sale Class A ordinary shares | -20 | $6.68 | $134 | 70,160 | Mar 24, 2026 |
| Mar 20, 2026 | BZ Kanzhun Ltd | MOption exercise Restricted Share Unitderivative | -4,308 | $0.00 | $0 | 0 | Mar 24, 2026 |
Questions about Wenbei Wang
Answered from the filings on this page, as of the latest one.
Is Wenbei Wang buying or selling?
In the last 12 months Wenbei Wang reported 0 open-market buys worth $0 and 2 open-market sells worth $5,581 on SEC Form 4; the latest was sold $5,447 of BZ on Mar 30, 2026. Grants, option exercises and tax withholding are not counted.
How did Wenbei Wang's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Wenbei Wang has 0.
Where does Wenbei Wang file Form 4?
Wenbei Wang has filed Form 4 at BZ (Kanzhun Ltd) as Deputy Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.